In the second episode of a 4-part podcast series on HCC, the Oncology Brothers, Drs Rahul and Rohit Gosain, host a podcast discussion between Dr Lorenza Rimassa and Prof. Arndt Vogel on 2nd line treatment selection in advanced HCC and when to switch.

The discussion covers a range of topics, including 2nd line options for advanced HCC after progression on 1st line TKIs and IO-based therapies, as well as:

This is the second video podcast episode in a 4-part series. Access the rest of the series here:

Part 1 - The use of IO in unresectable HCC

Part 3 - Intermediate HCC: treatment options and strategies (coming soon)

Part 4 - The evolving role of IO in intermediate HCC (coming soon)

Clinical takeaways

Don't forget to like, subscribe, and check out more episodes for in-depth discussions on oncology topics!

Website: http://www.oncbrothers.com/

X/Twitter: https://twitter.com/oncbrothers

Contact us at [email protected]